The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).

[1]  H. Halperin,et al.  Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[2]  G. Fontaine,et al.  Implantable cardioverter defibrillator in arrhythmogenic right ventricular cardiomyopathies. , 2004, Circulation.

[3]  G. Breithardt,et al.  Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy: Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients , 2004, Circulation.

[4]  M. Link,et al.  Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[5]  N. Freimer,et al.  The Newfoundland population: a unique resource for genetic investigation of complex diseases. , 2003, Human molecular genetics.

[6]  B. Fernandez,et al.  Predictive, pre‐natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000 , 2003, Clinical genetics.

[7]  Elizabeth A. Krupinski,et al.  MR Imaging of Arrhythmogenic Right Ventricular Cardiomyopathy: Morphologic Findings and Interobserver Reliability , 2003, Cardiology.

[8]  H. Calkins,et al.  Magnetic Resonance Imaging Findings in Patients Meeting Task Force Criteria for Arrhythmogenic Right Ventricular Dysplasia , 2003, Journal of cardiovascular electrophysiology.

[9]  陈新,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmic devices , 2002 .

[10]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[11]  G. Danieli,et al.  Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.

[12]  M. S. Hamid,et al.  Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. , 2002, Journal of the American College of Cardiology.

[13]  A. Karchmer,et al.  Infections of intracardiac devices. , 2002, Infectious disease clinics of North America.

[14]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[15]  C. D. De Pasquale,et al.  Left sided arrhythmogenic ventricular dysplasia in siblings , 2001, Heart.

[16]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[17]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[18]  L. Jordaens,et al.  Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias , 2001, Heart.

[19]  G. Danieli,et al.  Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[20]  S. Osswald,et al.  Methods of minimizing inappropriate implantable cardioverter-defibrillator shocks , 2000, Current cardiology reports.

[21]  W. Mckenna,et al.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Need for an international registry (Reprinted from Circulation Online, March 21, pg E101, 2000) , 2000 .

[22]  F. Gaita,et al.  Adipose replacement and wall motion abnormalities in right ventricle arrhythmias: evaluation by MR imaging. Retrospective evaluation on 124 patients , 2000, The International Journal of Cardiac Imaging.

[23]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[24]  G. Danieli,et al.  Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1q42-43. , 2000, The American journal of cardiology.

[25]  D. Valle,et al.  Online Mendelian Inheritance In Man (OMIM) , 2000, Human mutation.

[26]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[27]  E. Stålberg,et al.  Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q , 1999 .

[28]  J. Zaidan.  Implantable cardioverter-defibrillators. , 1999, Journal of cardiothoracic and vascular anesthesia.

[29]  M. Gardner,et al.  Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. , 1998, Circulation.

[30]  D. Böcker,et al.  Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure. , 1998, Circulation.

[31]  R. Virmani,et al.  Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? , 1998, Circulation.

[32]  G. Fontaine,et al.  Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnoses. , 1998, Circulation.

[33]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[34]  G. Danieli,et al.  ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. , 1997, Genomics.

[35]  G. Danieli,et al.  Arrhythmogenic right ventricular cardiomyopathy a still underrecognized clinic entity. , 1997, Trends in cardiovascular medicine.

[36]  S. Nisam,et al.  Mortality trials with implantable defibrillators. , 1997, The American journal of cardiology.

[37]  Paul J. Wang,et al.  Arrhythmogenic Right Ventricular Dysplasia: Clinical Results with Implantable Cardioverter Defibrillators , 1997, Journal of Interventional Cardiac Electrophysiology.

[38]  L. Mestroni,et al.  A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. , 1996, Genomics.

[39]  G. Danieli,et al.  A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. , 1995, Human molecular genetics.

[40]  K. Bailey,et al.  Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. , 1995, The American journal of cardiology.

[41]  G Thiene,et al.  The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. , 1994, Human molecular genetics.

[42]  H. Scheld,et al.  Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. , 1994, American heart journal.

[43]  G. Thiene,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[44]  A. Read,et al.  Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register. , 1994, Journal of medical genetics.

[45]  W. Shimizu,et al.  [Arrhythmogenic right ventricular dysplasia (ARVD)]. , 1991, Nihon rinsho. Japanese journal of clinical medicine.

[46]  M. Kaneko,et al.  Arrhythmogenic right ventricular dysplasia with massive involvement of the left ventricle. , 1991, The Canadian journal of cardiology.

[47]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[48]  D. Corrado,et al.  Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. , 1990, The American journal of medicine.

[49]  G. Thiene,et al.  Right ventricular dysplasia: a familial cardiomyopathy? , 1989, European heart journal.

[50]  G. Thiene,et al.  Familial occurrence of right ventricular dysplasia: a study involving nine families. , 1988, Journal of the American College of Cardiology.

[51]  G. Thiene,et al.  Juvenile sudden death and effort ventricular tachycardias in a family with right ventricular cardiomyopathy. , 1988, International journal of cardiology.

[52]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[53]  B. Olsson,et al.  A long term follow up of 15 patients with arrhythmogenic right ventricular dysplasia. , 1987, British heart journal.

[54]  G. Thiene,et al.  A polymorphic form of familial arrhythmogenic right ventricular dysplasia. , 1987, The American journal of cardiology.

[55]  G. Fontaine,et al.  Familial arrhythmogenic right ventricular disease. , 1986, The American journal of cardiology.

[56]  J. Ryan,et al.  Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. , 1986, Circulation.

[57]  M. Eldar,et al.  Arrhythmogenic right ventricular dysplasia in a family. , 1985, The American journal of cardiology.

[58]  H. Ibsen,et al.  Familial right ventricular dilated cardiomyopathy. , 1985, British heart journal.

[59]  R Frank,et al.  Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.

[60]  J. Ware,et al.  Echocardiographic Measurements in Normal Subjects from Infancy to Old Age , 1980, Circulation.

[61]  J. Ware,et al.  Echocardiographic Measurements in Normal Subjects , 1978, Circulation.

[62]  G. Danieli,et al.  Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes , 2003, European Journal of Human Genetics.

[63]  G. Gregoratos,et al.  ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Journal of the American College of Cardiology.

[64]  B. Wilkoff,et al.  The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. , 2001, Current opinion in cardiology.

[65]  M. Gardner,et al.  The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14. , 2000, American journal of human genetics.

[66]  C. Blomström-Lundqvist,et al.  Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. , 1999, Annals of neurology.

[67]  R. Dietz,et al.  A rapid protocol for cardiac troponin T gene mutation detection in familial hypertrophic cardiomyopathy , 1998, Human mutation.

[68]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.

[69]  S. Peters,et al.  Risk factors of cardiac arrest in arrhythmogenic right ventricular dysplasia. , 1995, European heart journal.